Cancer genomes exhibit a large number of different alterations that affect many genes in a diverse manner. It is widely believed that these alterations follow combinatorial patterns that have a strong connection with the underlying molecular interaction networks and functional pathways. A better understanding of the generative mechanisms behind the mutation rules and their influence on gene communities is of great importance for the process of driver mutations discovery and for identification of network modules related to cancer development and progression. We developed a new method for cancer mutation pattern analysis based on a constrained form of correlation clustering. Correlation clustering is an agnostic learning method that can be used for general community detection problems in which the number of communities or their structure is not known beforehand. The resulting algorithm, named $C^3$, leverages mutual exclusivity of mutations, patient coverage, and driver network concentration principles; it accepts as its input a user determined combination of heterogeneous patient data, such as that available from TCGA (including mutation, copy number, and gene expression information), and creates a large number of clusters containing mutually exclusive mutated genes in a particular type of cancer. The cluster sizes may be required to obey some useful soft size constraints, without impacting the computational complexity of the algorithm. To test $C^3$, we performed a detailed analysis on TCGA breast cancer and glioblastoma data and showed that our algorithm outperforms the state-of-the-art CoMEt method in terms of discovering mutually exclusive gene modules and identifying driver genes. Our $C^3$ method represents a unique tool for efficient and reliable identification of mutation patterns and driver pathways in large-scale cancer genomics studies.
PET/CT Radiogenomic Mutation Prediction in Non-Small Cell Lung Cancer Using Multi-Label Learning
Nuffield Department of Population Health, University of Oxford(牛津大学纳菲尔德人口健康系);Oxford University Hospitals NHS FT(牛津大学医院国民保健信托基金会);Department of Oncology, University of Oxford(牛津大学肿瘤学系);Department of Medical Physics and Clinical Engineering, Oxford University Hospitals NHS FT(牛津大学医院国民保健信托基金会医学物理与临床工程系)
A Hybrid Machine Learning Model for Classifying Gene Mutations in Cancer using LSTM, BiLSTM, CNN, GRU, and GloVe
Maharishi International University(玛赫西国际大学);Luther College(路德学院);Al-Balqa Applied University(巴尔卡应用大学);Skyline University College(天际线大学学院);Sultan Qaboos University(苏丹卡布斯大学)
An unsupervised clustering analysis of breast cancer data derived from electronic health records enhanced through UMAP dimensionality reduction
Dipartimento di Informatica Sistemistica e Comunicazione, Università di Milano-Bicocca(信息系统与通信系,米兰比可卡大学);Institute of Health Policy Management and Evaluation, University of Toronto(卫生政策管理与评估研究所,多伦多大学)
DPSeq: A Novel and Efficient Digital Pathology Classifier for Predicting Cancer Biomarkers using Sequencer Architecture
School of Data Science, University of Science and Technology of China(中国科学技术大学数据科学学院);School of Management, University of Science and Technology of China(中国科学技术大学管理学院);School of Population Health, UNSW Sydney(新南威尔士大学悉尼分校人口健康学院);Genmab Inc.(杰特贝公司)
Predicting drug response of tumors from integrated genomic profiles by deep neural networks
Greehey Children’s Cancer Research Institute, University of Texas Health Science Center at San Antonio(德克萨斯大学圣安东尼奥健康科学中心格里希儿童癌症研究所);University of Texas at San Antonio(德克萨斯大学圣安东尼奥分校);Northwestern Polytechnical University(西北工业大学);Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio(德克萨斯大学圣安东尼奥健康科学中心流行病学与生物统计学系)
EGFR Mutation Prediction of Lung Biopsy Images using Deep Learning
Indian Institute of Technology, Bombay(印度理工学院孟买分校);Tata Memorial Centre-ACTREC, HBNI(霍米·巴巴国立研究所塔塔纪念中心-先进治疗研究与教育中心);Tata Memorial Centre-TMH, HBNI(霍米·巴巴国立研究所塔塔纪念中心-塔塔纪念医院)